Medicine and Dentistry
COVID-19
100%
Hepatitis C Virus
55%
Autoimmune Hepatitis
55%
Liver Graft
55%
Alanine Aminotransferase
43%
Transplantation
40%
Liver Injury
37%
Liver Cirrhosis
34%
Aspartate Aminotransferase
31%
Liver Support
27%
Severe Acute Respiratory Syndrome Coronavirus 2
27%
Pediatrics
27%
Heart Transplantation
27%
Carotid Atherosclerosis
27%
Cohort Effect
27%
Extracorporeal Membrane Oxygenation
27%
Retransplantation
27%
Septic Shock
27%
Hepatocellular Carcinoma
27%
Immunosuppressive Drug
27%
Finegoldia magna
27%
Acute Liver Failure
27%
Malignant Neoplasm
27%
Liver Disease
25%
Infection
20%
Sepsis
18%
Decision Making
18%
Disease
17%
Immunosuppressive Treatment
14%
Odds Ratio
14%
Hepatitis C
13%
Coronary Artery Disease
13%
Neoplasm
13%
Chronic Liver Disease
11%
Patient Population
9%
Hepatic Encephalopathy
9%
Liver Cancer
9%
End Stage Liver Disease
9%
Postoperative Complication
9%
Invasive Procedure
9%
Glucocorticoid
8%
Mercaptopurine
8%
Prevalence
6%
Atherosclerosis
6%
Health Outcomes
6%
Observational Study
6%
Lactate Dehydrogenase
6%
Controlled Clinical Trial
6%
Ferritin
6%
Lymphocyte
6%
Keyphrases
COVID-19
63%
Alanine Aminotransferase
38%
Cirrhosis
31%
Aspartate Aminotransferase
30%
Extracorporeal Liver Support
27%
Immunosuppressive Drugs
27%
Coronary Atherosclerosis
27%
Liver Injury
27%
Carotid Atherosclerosis
27%
Finegoldia Magna
27%
Native Valve
27%
Molecular Adsorbent Recirculating System
27%
Hepatitis C Virus
27%
Mortality Prediction
27%
Hepatic Functional Reserve
27%
COVID-19 Patients
27%
Clinical Variables
27%
Pediatric
27%
Acute Liver Failure
27%
Longitudinal Progression
27%
Autoimmune Hepatitis
27%
Metabolic Risk Factors
27%
Metabolic Obesity
27%
Liver Transplant Recipients
27%
Metabolic Dysfunction
27%
Metabolic Health
27%
Plaque Formation
20%
Comorbidity
17%
Hepatitis C Virus Infection
13%
Early Tumor Detection
13%
Post-liver Transplant
13%
Liver Transplant Evaluation
13%
Preoperative Risk Assessment
13%
Anatomical Constraints
13%
Strict Control
13%
Alcohol Use Disorder
13%
Complications of Liver Transplantation
13%
Bariatric Surgery
13%
Liver Disease
13%
Immunosuppressive Therapy
13%
Patient Demographics
13%
Sarcopenic Obesity
13%
Growing Patients
13%
Operative
13%
Liver Failure
13%
Metabolic-associated Fatty Liver Disease (MAFLD)
13%
Chronic Liver Disease
13%
Renal Disease
13%
Cardiovascular Risk
13%
Hospitalization
13%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis C Virus
55%
Autoimmune Hepatitis
55%
Liver Injury
43%
Coronary Artery Atherosclerosis
27%
Disease
27%
Carotid Atherosclerosis
27%
Immunosuppressive Agent
27%
Coronavirinae
27%
Hepatitis C
13%
Coronary Artery Disease
13%
Alanine Aminotransferase
13%
Glucocorticoid
8%
Mercaptopurine
8%
Liver Cirrhosis
7%
Chronic Liver Disease
7%
Controlled Clinical Trial
6%
Inflammation
6%
Observational Study
6%
Atherosclerosis
6%
Ferritin
6%
Infection
6%
Prevalence
6%
Lactate Dehydrogenase
6%
Tacrolimus
5%
Mycophenolic Acid
5%
Antivirus Agent
5%